The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.
New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice
- Post author:
- Post published:October 15, 2023
- Post category:uncategorized